Renal retransplantation in adults;Retransplantation rénale chez l'adulte Etude pronostique comparative

Progres en Urologie

Volumn 9, Issue 2, 1999, Pages 239-243

  Mouquet, Catherine ^a   Benalia, Hadjira ^a   Chartier Kastler, Emmanuel ^a   Sylla, Cheickna ^a   Coriat, Pierre ^a   Bitker, Marc Olivier ^a   Richard, François ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Long term outcome; Prognosis; Renal retransplantation; Repeated transplantations

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; METHODOLOGY; MORTALITY; PHYSIOLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY; REOPERATION; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RENAL REPLACEMENT THERAPY; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0346333380     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ALEXANDER S.I., YOUNES S.B., ZURAKOWSKI D., et al. Cell-mediated cytotoxicity : a predictor of chronic rejection in pediatric HLA haploidentical renal transplants. Transplantation, 1997, 63, 1756-1761.
2. ALMOND P.S , MATAS A.J., GILLINGHAM K., TROPPMANN C., PAYNE W., DUNN D., SUTHERLAND D. Risk factors for second renal allografts immunosuppressed with Cyclosporine.Transplantation. 1991, 52, 253-258.
3. BITKER M.O., MOUQUET C., BARROU B., BENALIA H., LUCIANI J., ROTTEMBOURG J., JACOBS C., CHATELAIN C. Transplantation rénale chez le patient hyperimmunisé : expérience du groupe hospitalier de la Pitié-Salpêtrière. Séminaires d'UroNéphrologie, XXIème série, pp : 403-408, 1995.
4. BITKER M.O., BAGNIS C., MOUQUET C., LUCIANI J., BENALIA H., CHATELAIN C. Transplantation rénale sans Ciclosporine en 1991 : résultats à 3 ans. La Presse Médicale, 1992, 21, 953 (lettre).
5. BUSSON M., BENOIT G. Is matching for sex and age beneficial to kidney graft survival? Société Française de Transplantation and Association France Transplant. Clinical Transplantation, 1997, 11, 15-18.
6. CARLIER M., SQUIFFLET J.P., PIRSON Y. DECOCQ L., GRIBOMONT B., ALEXANDRE G.P.J. Confirmation of the crucial role of the recipient's maximal hydration on early diuresis of the human cadaver renal allograft. Transplantation, 1983, 36, 455-456.
7. HEISE E.R., THACKER L.R., MACQUEEN J.M., PETERS T.G. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation. Clinical Transplantation, 1996, 10, 579-585.
8. HIRATA M., TERASAKI P.I. Renal retransplantation. Clinical Transplants, 1994, 419-433.
9. HOWARD R.J., SCORNIK J., FENNELL R., PFAFF W.W. Results of kidney retransplantation. Arch. Surg., 1984, 119, 796-799.
10. ISOMIEMI H., LEHTONEN S., SALMELA K., AHONEN J. Does delayed kidney graft function increase the risk of chronic rejection? Transplant International, 1996, 9, S1, 51, 5-7.
11. JACKSON C.L., NOVICK A.C., STREEM S.B., STEINMULLER D., CUNNINGHAM R., HODGE E., BADHWAR K. Recent results of cadaver kidney retransplantation. J. Urol., 1989, 142, 694-696.
12. LEHTONEN S.R., ISONIEMI H.M., SALMELA K.T., TASKINEN E.I., WILLEBRAND E.O., AHONEN J.P. Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. Transplantation, 1997, 64, 103-107.
13. Le rapport du Conseil Médical et Scientifique de l'Etablissement Français des Greffes sur le prélèvement et la greffe en France en 1997 (à paraître).
14. LUCIANI J., FRANTZ P., THIBAULT P., GHESQUIERES F., CONSEILLER C., COUSIN M.T., GLASER P., LEGRAIN M., VIARS P., KÜSS R. Early anuria prevention in human kidney transplantation. Transplantation, 1979, 28, 308-312.
15. PASTURAL M., BARROU B., GOLMARD J.L., GORICHON-RADIDEAU E., MANIGHETTI J., OURAHMA S., BENALIA H., MOUQUET C., CHATELAIN C., BITKER M.O. Utilisation du Mycophénolate Mofétil (MMF) en transplantation rénale : résultat d'une expérience inonocentrique. Prog. Urol., sous presse.
16. PERALDI M.N., AKPOSSO K., HAYMANN J.P., FLAHAUT A., MARLIN C., RONDEAU E., SRAER J.D. Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation. Transplantation, 1996, 62, 11, 1670-1673.
17. ROSENTHAL JT., HAKALA T.R., STARZL T., IWATSUKI S., SHAW B.W. Second cadaver kidney transplants : improved graft survival in secondary kidney transplants using Cyclosporin A. J. Urol,1984, 131, 17-18.
18. SHAPIRO R., VIVAS C., SCANTLEBURY V.P., JORDAN M.L., GRITSCH H.A., NEUGARTEN J., Mc CAULEY J., RANDHAWA P., IRISH W., FUNG J.J., HAKALA T., SIMMONS R.L., STARZL T.E. «Suboptimal» kidney donors : the experience with tacrolimus-based immunosuppression. Transplantation, 1996, 62, 1242-1246.
19. TEJANI A., SULLIVAN EK. Factors that impact on the outcome of second renal transplants in children. Transplantation, 1996, 62, 606-611.
20. THOROGOOD J., HOUWELINGEN J.C., PERSON G.G., ZANTVOORT F.A., SCHREUDER G.M.T., VAN ROOD J.J. Prognostic indices to predict survival of first and second renal allografts. Transplantation, 1991, 52, 831-836
21. TROPPMANN C., BENEDETTI E., GRUESSNER R.W., PAYNE W.D., SUTHERLAND D.E., NAJARIAN J.S., MATAS A.J. Retransplantation after renal allograft loss due to noncompliance. Indications, outcome, and ethical concerns. Transplantation, 1995, 59, 467-471.